Distinct innate immune gene expression profiles in non-melanoma skin cancer of immunocompetent and immunosuppressed patients

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Muehleisen, Beda ^a,b   Jiang, Shang Brian ^a   Gladsjo, Julie A ^a   Gerber, Monika ^a   Hata, Tissa ^a   Gallo, Richard L ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 10; FILAGGRIN; GAMMA INTERFERON; MESSENGER RNA; PSORIASIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; INNATE IMMUNITY; MALE; PROTEIN EXPRESSION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR IMMUNITY;

AGED; ANTIMICROBIAL CATIONIC PEPTIDES; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CYTOKINES; EPIDERMIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; IMMUNITY, INNATE; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; MALE; MELANOMA; ORGAN TRANSPLANTATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TOLL-LIKE RECEPTORS;

EID: 84863763258     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040754     Document Type: Article

References (55)

1. Lomas A, Leonardi-Bee J, Bath-Hextall F, (2012) A Systematic Review of worldwide incidence of Non-melanoma skin cancer. Br J Dermatol.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
3. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, et al. (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146: 283-287.
4. Berg D, Otley CC, (2002) Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 47: 1-17; quiz 18-20.
5. Norval M, (2001) Effects of solar radiation on the human immune system. J Photochem Photobiol B 63: 28-40.
6. O'Dell BL, Jessen RT, Becker LE, Jackson RT, Smith EB, (1980) Diminished immune response in sun-damaged skin. Arch Dermatol 116: 559-561.
7. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD, (2002) Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3: 991-998.
8. Schreiber RD, Old LJ, Smyth MJ, (2011) Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331: 1565-1570.
9. Coley WB, (1991) The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop Relat Res pp. 3-11.
10. Starnes CO, (1992) Coley's toxins in perspective. Nature 357: 11-12.
11. Lai Y, Gallo RL, (2008) Toll-like receptors in skin infections and inflammatory diseases. Infect Disord Drug Targets 8: 144-155.
12. Lai Y, Gallo RL, (2009) AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30: 131-141.
13. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347: 1151-1160.
14. Schauber J, Gallo RL, (2009) Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 124: R13-18.
15. Zanetti M, (2005) The role of cathelicidins in the innate host defenses of mammals. Curr Issues Mol Biol 7: 179-196.
16. Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, et al. (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117: 91-97.
17. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, et al. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454-457.
18. Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, et al. (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111: 1665-1672.
19. Kesting MR, Sudhoff H, Hasler RJ, Nieberler M, Pautke C, et al. (2009) Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features. Oral Oncol 45: 731-736.
20. Yoshimoto T, Yamaai T, Mizukawa N, Sawaki K, Nakano M, et al. (2003) Different expression patterns of beta-defensins in human squamous cell carcinomas. Anticancer Res 23: 4629-4633.
21. Buchau AS, Morizane S, Trowbridge J, Schauber J, Kotol P, et al. (2010) The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth. J Immunol 184: 369-378.
22. Wagstaff AJ, Perry CM, (2007) Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions. Drugs 67: 2187-2210.
23. Braff MH, Bardan A, Nizet V, Gallo RL, (2005) Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol 125: 9-13.
24. Glaser R, Harder J, Lange H, Bartels J, Christophers E, et al. (2005) Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 6: 57-64.
25. Glaser R, Koten B, Wittersheim M, Harder J, (2011) Psoriasin: key molecule of the cutaneous barrier? J Dtsch Dermatol Ges 9: 897-902.
26. Kisich KO, Howell MD, Boguniewicz M, Heizer HR, Watson NU, et al. (2007) The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. J Invest Dermatol 127: 2368-2380.
27. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, et al. (1999) Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23: 41-46.
28. Wang Z, Gerstein M, Snyder M, (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10: 57-63.
29. Hudson LG, Gale JM, Padilla RS, Pickett G, Alexander BE, et al. (2010) Microarray analysis of cutaneous squamous cell carcinomas reveals enhanced expression of epidermal differentiation complex genes. Mol Carcinog 49: 619-629.
30. Huang B, Zhao J, Unkeless JC, Feng ZH, Xiong H, (2008) TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27: 218-224.
31. Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, et al. (2006) TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 66: 3859-3868.
32. Lee JW, Choi JJ, Seo ES, Kim MJ, Kim WY, et al. (2007) Increased toll-like receptor 9 expression in cervical neoplasia. Mol Carcinog 46: 941-947.
33. Szczepanski M, Stelmachowska M, Stryczynski L, Golusinski W, Samara H, et al. (2007) Assessment of expression of toll-like receptors 2, 3 and 4 in laryngeal carcinoma. Eur Arch Otorhinolaryngol 264: 525-530.
34. Vahle AK, Kerem A, Ozturk E, Bankfalvi A, Lang S, et al. (2012) Optimization of an orthotopic murine model of head and neck squamous cell carcinoma in fully immunocompetent mice-role of toll-like-receptor 4 expressed on host cells. Cancer Lett 317: 199-206.
35. Schauber J, Dorschner RA, Coda AB, Buchau AS, Liu PT, et al. (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117: 803-811.
36. Frye M, Bargon J, Gropp R, (2001) Expression of human beta-defensin-1 promotes differentiation of keratinocytes. J Mol Med (Berl) 79: 275-282.
37. Kawsar HI, Ghosh SK, Hirsch SA, Koon HB, Weinberg A, et al. (2010) Expression of human beta-defensin-2 in intratumoral vascular endothelium and in endothelial cells induced by transforming growth factor beta. Peptides 31: 195-201.
38. Sawaki K, Mizukawa N, Yamaai T, Yoshimoto T, Nakano M, et al. (2002) High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 22: 2103-2107.
39. Jin G, Kawsar HI, Hirsch SA, Zeng C, Jia X, et al. (2010) An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS One 5: e10993.
40. Gambichler T, Skrygan M, Huyn J, Bechara FG, Sand M, et al. (2006) Pattern of mRNA expression of beta-defensins in basal cell carcinoma. BMC Cancer 6: 163.
41. Mburu YK, Abe K, Ferris LK, Sarkar SN, Ferris RL, (2011) Human beta-defensin 3 promotes NF-kappaB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck. Carcinogenesis 32: 168-174.
42. Moubayed N, Weichenthal M, Harder J, Wandel E, Sticherling M, et al. (2007) Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol 133: 253-261.
43. Wolf R, Voscopoulos C, Winston J, Dharamsi A, Goldsmith P, et al. (2009) Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancer. Cancer Lett 277: 101-107.
44. Al-Haddad S, Zhang Z, Leygue E, Snell L, Huang A, et al. (1999) Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 155: 2057-2066.
45. Emberley ED, Alowami S, Snell L, Murphy LC, Watson PH, (2004) S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast. Breast Cancer Res 6: R308-315.
46. Leygue E, Snell L, Hiller T, Dotzlaw H, Hole K, et al. (1996) Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res 56: 4606-4609.
47. Morgan MR, Jazayeri M, Ramsay AG, Thomas GJ, Boulanger MJ, et al. (2011) Psoriasin (S100A7) associates with integrin beta6 subunit and is required for alphavbeta6-dependent carcinoma cell invasion. Oncogene 30: 1422-1435.
48. Krynitz B, Lundh Rozell B, Lindelof B, (2010) Differences in the peritumoural inflammatory skin infiltrate between squamous cell carcinomas in organ transplant recipients and immunocompetent patients. Acta Derm Venereol 90: 379-385.
49. Muhleisen B, Petrov I, Gachter T, Kurrer M, Scharer L, et al. (2009) Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate. Histopathology 55: 67-76.
50. Mathew T, Kreis H, Friend P, (2004) Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies. Clin Transplant 18: 446-449.
51. Liu AY, Destoumieux D, Wong AV, Park CH, Valore EV, et al. (2002) Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 118: 275-281.
52. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, et al. (2002) Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277: 15028-15034.
53. Kuhns DB, Priel DA, Gallin JI, (2007) Induction of human monocyte interleukin (IL)-8 by fibrinogen through the toll-like receptor pathway. Inflammation 30: 178-188.
54. Euvrard S, Kanitakis J, Claudy A, (2003) Skin cancers after organ transplantation. N Engl J Med 348: 1681-1691.
55. Cumberland L, Dana A, Liegeois N, (2009) Mohs micrographic surgery for the management of nonmelanoma skin cancers. Facial Plast Surg Clin North Am 17: 325-335.